New England Biolabs launches new NEBNext Ultra kits at ASHG annual meeting

New England Biolabs, Inc. (NEB) launched their new NEBNext® "Ultra" kits at the recent American Society for Human Genetics (ASHG) annual meeting. These kits provide streamlined, low-input methods to prepare DNA and RNA libraries for Illumina® next generation sequencing. The supplied protocols and reagents are designed to maximize useful data from a broad range of samples, including those available in limited amounts.

The NEBNext Ultra DNA and Ultra RNA Library Kits produce high-yield libraries from 5 ng to 1 ug of input DNA, or as little as 10 ng of input RNA. The input RNA can be total RNA, purified mRNA or rRNA-depleted RNA.

Early access user Cynthia Hendrickson, Ph.D., at the HudsonAlpha Institute for Biotechnology, reports that in initial experiments, NEB's new method "has allowed us to reduce our DNA inputs for exome enrichment from micrograms to a few hundred nanograms, while providing a simpler, faster protocol that minimizes the amount of hands-on time required."

Another early access user, Momchilo Vuyisich, Ph.D., at the Los Alamos National Laboratory, says, "After testing several NGS library prep kits, we have found that the NEBNext Ultra DNA kit for Illumina has the best overall utility for resequencing and assembly of bacterial genomes. The kit offers an unmatched combination of ease-of-use, low cost, robustness and low input DNA requirements. It consistently produces excellent sequencing data."

The new Ultra kits contain novel ligation reagents, as well as NEB's NEBNext NGS-optimized formulation of Q5® High-Fidelity DNA polymerase, which provides ultra high-fidelity amplification and minimized GC bias.

NEB's streamlined protocol for constructing DNA libraries with the Ultra kit requires only 15 minutes of hands-on-time, and is complete in 2.5 hours. The Ultra RNA workflow also incorporates a streamlined protocol; the workflow is complete in 4-5 hours, with only 30 minutes of hands-on time.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    New England Biolabs. (2019, June 19). New England Biolabs launches new NEBNext Ultra kits at ASHG annual meeting. News-Medical. Retrieved on November 23, 2024 from https://www.news-medical.net/news/20121117/New-England-Biolabs-launches-new-NEBNext-Ultra-kits-at-ASHG-annual-meeting.aspx.

  • MLA

    New England Biolabs. "New England Biolabs launches new NEBNext Ultra kits at ASHG annual meeting". News-Medical. 23 November 2024. <https://www.news-medical.net/news/20121117/New-England-Biolabs-launches-new-NEBNext-Ultra-kits-at-ASHG-annual-meeting.aspx>.

  • Chicago

    New England Biolabs. "New England Biolabs launches new NEBNext Ultra kits at ASHG annual meeting". News-Medical. https://www.news-medical.net/news/20121117/New-England-Biolabs-launches-new-NEBNext-Ultra-kits-at-ASHG-annual-meeting.aspx. (accessed November 23, 2024).

  • Harvard

    New England Biolabs. 2019. New England Biolabs launches new NEBNext Ultra kits at ASHG annual meeting. News-Medical, viewed 23 November 2024, https://www.news-medical.net/news/20121117/New-England-Biolabs-launches-new-NEBNext-Ultra-kits-at-ASHG-annual-meeting.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New England Biolabs inks deal to supply critical reagents to TriLink BioTechnologies